Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 124

1.

Alterations in pectoralis muscle cell characteristics after radiation of the human breast in situ.

Wallner C, Drysch M, Hahn SA, Becerikli M, Puscz F, Wagner JM, Sacher M, Sogorski A, Dadras M, Lehnhardt M, Behr B.

J Radiat Res. 2019 Oct 28. pii: rrz067. doi: 10.1093/jrr/rrz067. [Epub ahead of print]

PMID:
31665379
2.

Cervical gonorrhea in a transgender man post hysterectomy.

Katz AR, Hahn SA, Tomas JE, Komeya AY.

Int J STD AIDS. 2019 Sep 27:956462419866048. doi: 10.1177/0956462419866048. [Epub ahead of print] No abstract available.

PMID:
31558123
3.

Loss of smooth muscle CYB5R3 amplifies angiotensin II-induced hypertension by increasing sGC heme oxidation.

Durgin BG, Hahn SA, Schmidt HM, Miller MP, Hafeez N, Mathar I, Freitag D, Sandner P, Straub AC.

JCI Insight. 2019 Oct 3;4(19). pii: 129183. doi: 10.1172/jci.insight.129183.

4.

Dose-Ranging and Cohort-Expansion Study of Monalizumab (IPH2201) in Patients with Advanced Gynecologic Malignancies: A Trial of the Canadian Cancer Trials Group (CCTG): IND221.

Tinker AV, Hirte HW, Provencher D, Butler M, Ritter H, Tu D, Azim HA Jr, Paralejas P, Grenier N, Hahn SA, Ramsahai J, Seymour L.

Clin Cancer Res. 2019 Oct 15;25(20):6052-6060. doi: 10.1158/1078-0432.CCR-19-0298. Epub 2019 Jul 15.

PMID:
31308062
5.

Antagonism of Forkhead Box Subclass O Transcription Factors Elicits Loss of Soluble Guanylyl Cyclase Expression.

Galley JC, Durgin BG, Miller MP, Hahn SA, Yuan S, Wood KC, Straub AC.

Mol Pharmacol. 2019 Jun;95(6):629-637. doi: 10.1124/mol.118.115386. Epub 2019 Apr 15.

PMID:
30988014
6.

Preclinical Efficacy of Covalent-Allosteric AKT Inhibitor Borussertib in Combination with Trametinib in KRAS-Mutant Pancreatic and Colorectal Cancer.

Weisner J, Landel I, Reintjes C, Uhlenbrock N, Trajkovic-Arsic M, Dienstbier N, Hardick J, Ladigan S, Lindemann M, Smith S, Quambusch L, Scheinpflug R, Depta L, Gontla R, Unger A, Müller H, Baumann M, Schultz-Fademrecht C, Günther G, Maghnouj A, Müller MP, Pohl M, Teschendorf C, Wolters H, Viebahn R, Tannapfel A, Uhl W, Hengstler JG, Hahn SA, Siveke JT, Rauh D.

Cancer Res. 2019 May 1;79(9):2367-2378. doi: 10.1158/0008-5472.CAN-18-2861. Epub 2019 Mar 11.

PMID:
30858154
7.

Clinical Policy: Critical Issues in the Evaluation and Management of Adult Patients Presenting to the Emergency Department With Suspected Acute Venous Thromboembolic Disease.

American College of Emergency Physicians Clinical Policies Subcommittee (Writing Committee) on Thromboembolic Disease:, Wolf SJ, Hahn SA, Nentwich LM, Raja AS, Silvers SM, Brown MD.

Ann Emerg Med. 2018 May;71(5):e59-e109. doi: 10.1016/j.annemergmed.2018.03.006. Review. No abstract available.

PMID:
29681319
8.

Nitric Oxide-Independent Soluble Guanylate Cyclase Activation Improves Vascular Function and Cardiac Remodeling in Sickle Cell Disease.

Potoka KP, Wood KC, Baust JJ, Bueno M, Hahn SA, Vanderpool RR, Bachman T, Mallampalli GM, Osei-Hwedieh DO, Schrott V, Sun B, Bullock GC, Becker-Pelster EM, Wittwer M, Stampfuss J, Mathar I, Stasch JP, Truebel H, Sandner P, Mora AL, Straub AC, Gladwin MT.

Am J Respir Cell Mol Biol. 2018 May;58(5):636-647. doi: 10.1165/rcmb.2017-0292OC.

9.

A genetic roadmap of pancreatic cancer: still evolving.

Notta F, Hahn SA, Real FX.

Gut. 2017 Dec;66(12):2170-2178. doi: 10.1136/gutjnl-2016-313317. Epub 2017 Oct 9. Review.

PMID:
28993418
10.

Targeting Pulmonary Endothelial Hemoglobin α Improves Nitric Oxide Signaling and Reverses Pulmonary Artery Endothelial Dysfunction.

Alvarez RA, Miller MP, Hahn SA, Galley JC, Bauer E, Bachman T, Hu J, Sembrat J, Goncharov D, Mora AL, Rojas M, Goncharova E, Straub AC.

Am J Respir Cell Mol Biol. 2017 Dec;57(6):733-744. doi: 10.1165/rcmb.2016-0418OC.

11.

Cytochrome b5 Reductase 3 Modulates Soluble Guanylate Cyclase Redox State and cGMP Signaling.

Rahaman MM, Nguyen AT, Miller MP, Hahn SA, Sparacino-Watkins C, Jobbagy S, Carew NT, Cantu-Medellin N, Wood KC, Baty CJ, Schopfer FJ, Kelley EE, Gladwin MT, Martin E, Straub AC.

Circ Res. 2017 Jul 7;121(2):137-148. doi: 10.1161/CIRCRESAHA.117.310705. Epub 2017 Jun 5.

12.

Correction: Correction to 'Clinical Policy: Critical Issues in the Initial Evaluation and Management of Patients Presenting to the Emergency Department in Early Pregnancy' [Annals of Emergency Medicine 69 (2017) 241-250.e20].

Hahn SA, Promes SB, Brown MD; American College of Emergency Physicians.

Ann Emerg Med. 2017 Nov;70(5):758. doi: 10.1016/j.annemergmed.2017.03.035. Epub 2017 Apr 7.

PMID:
28395924
13.

Clinical Policy: Critical Issues in the Initial Evaluation and Management of Patients Presenting to the Emergency Department in Early Pregnancy.

American College of Emergency Physicians Clinical Policies Subcommittee (Writing Committee) on Early Pregnancy:, Hahn SA, Promes SB, Brown MD.

Ann Emerg Med. 2017 Feb;69(2):241-250.e20. doi: 10.1016/j.annemergmed.2016.11.002. Review. No abstract available. Erratum in: Ann Emerg Med. 2017 Nov;70(5):758.

PMID:
28126120
14.

Circular RNA expression in cutaneous squamous cell carcinoma.

Sand M, Bechara FG, Gambichler T, Sand D, Bromba M, Hahn SA, Stockfleth E, Hessam S.

J Dermatol Sci. 2016 Sep;83(3):210-8. doi: 10.1016/j.jdermsci.2016.05.012. Epub 2016 May 25.

PMID:
27298156
15.

A key role of GARP in the immune suppressive tumor microenvironment.

Hahn SA, Neuhoff A, Landsberg J, Schupp J, Eberts D, Leukel P, Bros M, Weilbaecher M, Schuppan D, Grabbe S, Tueting T, Lennerz V, Sommer C, Jonuleit H, Tuettenberg A.

Oncotarget. 2016 Jul 12;7(28):42996-43009. doi: 10.18632/oncotarget.9598.

16.

Circular RNA expression in basal cell carcinoma.

Sand M, Bechara FG, Sand D, Gambichler T, Hahn SA, Bromba M, Stockfleth E, Hessam S.

Epigenomics. 2016 May;8(5):619-32. doi: 10.2217/epi-2015-0019. Epub 2016 Apr 20.

PMID:
27097056
17.

Expression profiles of long noncoding RNAs in cutaneous squamous cell carcinoma.

Sand M, Bechara FG, Sand D, Gambichler T, Hahn SA, Bromba M, Stockfleth E, Hessam S.

Epigenomics. 2016 Apr;8(4):501-18. doi: 10.2217/epi-2015-0012. Epub 2016 Apr 12.

PMID:
27067026
18.

How Soluble GARP Enhances TGFβ Activation.

Fridrich S, Hahn SA, Linzmaier M, Felten M, Zwarg J, Lennerz V, Tuettenberg A, Stöcker W.

PLoS One. 2016 Apr 7;11(4):e0153290. doi: 10.1371/journal.pone.0153290. eCollection 2016.

19.

GARP inhibits allergic airway inflammation in a humanized mouse model.

Meyer-Martin H, Hahn SA, Beckert H, Belz C, Heinz A, Jonuleit H, Becker C, Taube C, Korn S, Buhl R, Reuter S, Tuettenberg A.

Allergy. 2016 Sep;71(9):1274-83. doi: 10.1111/all.12883. Epub 2016 Apr 1.

PMID:
26990894
20.

Kinome Profiling of Regulatory T Cells: A Closer Look into a Complex Intracellular Network.

Tuettenberg A, Hahn SA, Mazur J, Gerhold-Ay A, Scholma J, Marg I, Ulges A, Satoh K, Bopp T, Joore J, Jonuleit H.

PLoS One. 2016 Feb 16;11(2):e0149193. doi: 10.1371/journal.pone.0149193. eCollection 2016.

21.

Long-noncoding RNAs in basal cell carcinoma.

Sand M, Bechara FG, Sand D, Gambichler T, Hahn SA, Bromba M, Stockfleth E, Hessam S.

Tumour Biol. 2016 Aug;37(8):10595-608. doi: 10.1007/s13277-016-4927-z. Epub 2016 Feb 9.

PMID:
26861560
22.

Translating Treg Therapy in Humanized Mice.

Hahn SA, Bellinghausen I, Trinschek B, Becker C.

Front Immunol. 2015 Dec 14;6:623. doi: 10.3389/fimmu.2015.00623. eCollection 2015. Review.

23.

Circulating U2 small nuclear RNA fragments as a diagnostic and prognostic biomarker in lung cancer patients.

Köhler J, Schuler M, Gauler TC, Nöpel-Dünnebacke S, Ahrens M, Hoffmann AC, Kasper S, Nensa F, Gomez B, Hahnemann M, Breitenbuecher F, Cheufou D, Özkan F, Darwiche K, Hoiczyk M, Reis H, Welter S, Eberhardt WE, Eisenacher M, Teschler H, Stamatis G, Schmiegel W, Hahn SA, Baraniskin A.

J Cancer Res Clin Oncol. 2016 Apr;142(4):795-805. doi: 10.1007/s00432-015-2095-y. Epub 2015 Dec 19.

PMID:
26687686
24.

Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma.

Mazur PK, Herner A, Mello SS, Wirth M, Hausmann S, Sánchez-Rivera FJ, Lofgren SM, Kuschma T, Hahn SA, Vangala D, Trajkovic-Arsic M, Gupta A, Heid I, Noël PB, Braren R, Erkan M, Kleeff J, Sipos B, Sayles LC, Heikenwalder M, Heßmann E, Ellenrieder V, Esposito I, Jacks T, Bradner JE, Khatri P, Sweet-Cordero EA, Attardi LD, Schmid RM, Schneider G, Sage J, Siveke JT.

Nat Med. 2015 Oct;21(10):1163-71. doi: 10.1038/nm.3952. Epub 2015 Sep 21.

25.

A subset of metastatic pancreatic ductal adenocarcinomas depends quantitatively on oncogenic Kras/Mek/Erk-induced hyperactive mTOR signalling.

Kong B, Wu W, Cheng T, Schlitter AM, Qian C, Bruns P, Jian Z, Jäger C, Regel I, Raulefs S, Behler N, Irmler M, Beckers J, Friess H, Erkan M, Siveke JT, Tannapfel A, Hahn SA, Theis FJ, Esposito I, Kleeff J, Michalski CW.

Gut. 2016 Apr;65(4):647-57. doi: 10.1136/gutjnl-2014-307616. Epub 2015 Jan 19.

PMID:
25601637
26.

Effectiveness of androgen-deprivation therapy and radiotherapy for older men with locally advanced prostate cancer.

Bekelman JE, Mitra N, Handorf EA, Uzzo RG, Hahn SA, Polsky D, Armstrong K.

J Clin Oncol. 2015 Mar 1;33(7):716-22. doi: 10.1200/JCO.2014.57.2743. Epub 2015 Jan 5.

27.

New insights in the composition of extracellular vesicles from pancreatic cancer cells: implications for biomarkers and functions.

Klein-Scory S, Tehrani MM, Eilert-Micus C, Adamczyk KA, Wojtalewicz N, Schnölzer M, Hahn SA, Schmiegel W, Schwarte-Waldhoff I.

Proteome Sci. 2014 Nov 18;12(1):50. doi: 10.1186/s12953-014-0050-5. eCollection 2014.

28.

Induction of pancreatic cancer cell migration by an autocrine epidermal growth factor receptor activation.

Stock AM, Hahn SA, Troost G, Niggemann B, Zänker KS, Entschladen F.

Exp Cell Res. 2014 Aug 15;326(2):307-14. doi: 10.1016/j.yexcr.2014.04.022. Epub 2014 May 5.

PMID:
24810090
29.

A microRNA-based test improves endoscopic ultrasound-guided cytologic diagnosis of pancreatic cancer.

Brand RE, Adai AT, Centeno BA, Lee LS, Rateb G, Vignesh S, Menard C, Wiechowska-Kozłowska A, Bołdys H, Hartleb M, Sanders MK, Munding JB, Tannapfel A, Hahn SA, Stefańczyk L, Tsongalis GJ, Whitcomb DC, Conwell DL, Morisset JA, Gardner TB, Gordon SR, Suriawinata AA, Lloyd MB, Wylie D, Labourier E, Andruss BF, Szafranska-Schwarzbach AE.

Clin Gastroenterol Hepatol. 2014 Oct;12(10):1717-23. doi: 10.1016/j.cgh.2014.02.038. Epub 2014 Mar 21.

PMID:
24662333
30.

Analysis of U2 small nuclear RNA fragments in the bile differentiates cholangiocarcinoma from primary sclerosing cholangitis and other benign biliary disorders.

Baraniskin A, Nöpel-Dünnebacke S, Schumacher B, Gerges C, Bracht T, Sitek B, Meyer HE, Gerken G, Dechene A, Schlaak JF, Schroers R, Pox C, Schmiegel W, Hahn SA.

Dig Dis Sci. 2014 Jul;59(7):1436-41. doi: 10.1007/s10620-014-3034-5. Epub 2014 Jan 31.

PMID:
24482036
31.

Economic empowerment of impoverished IPV survivors: a review of best practice literature and implications for policy.

Hahn SA, Postmus JL.

Trauma Violence Abuse. 2014 Apr;15(2):79-93. doi: 10.1177/1524838013511541. Epub 2013 Dec 16. Review.

PMID:
24346706
32.

Circulating U2 small nuclear RNA fragments as a novel diagnostic tool for patients with epithelial ovarian cancer.

Kuhlmann JD, Baraniskin A, Hahn SA, Mosel F, Bredemeier M, Wimberger P, Kimmig R, Kasimir-Bauer S.

Clin Chem. 2014 Jan;60(1):206-13. doi: 10.1373/clinchem.2013.213066. Epub 2013 Nov 8.

33.

Lentiviral overexpression of miRNAs.

Zöllner H, Hahn SA, Maghnouj A.

Methods Mol Biol. 2014;1095:177-90. doi: 10.1007/978-1-62703-703-7_15.

PMID:
24166313
34.

Quantitative RT-PCR specific for precursor and mature miRNAs.

Zöllner H, Hahn SA, Maghnouj A.

Methods Mol Biol. 2014;1095:121-34. doi: 10.1007/978-1-62703-703-7_10.

PMID:
24166308
35.

The pancreatic expression database: recent extensions and updates.

Dayem Ullah AZ, Cutts RJ, Ghetia M, Gadaleta E, Hahn SA, Crnogorac-Jurcevic T, Lemoine NR, Chelala C.

Nucleic Acids Res. 2014 Jan;42(Database issue):D944-9. doi: 10.1093/nar/gkt959. Epub 2013 Oct 25.

36.

Keratin23 (KRT23) knockdown decreases proliferation and affects the DNA damage response of colon cancer cells.

Birkenkamp-Demtröder K, Hahn SA, Mansilla F, Thorsen K, Maghnouj A, Christensen R, Øster B, Ørntoft TF.

PLoS One. 2013 Sep 9;8(9):e73593. doi: 10.1371/journal.pone.0073593. eCollection 2013.

37.

Multimodal Treatment Eliminates Cancer Stem Cells and Leads to Long-Term Survival in Primary Human Pancreatic Cancer Tissue Xenografts.

Hermann PC, Trabulo SM, Sainz B Jr, Balic A, Garcia E, Hahn SA, Vandana M, Sahoo SK, Tunici P, Bakker A, Hidalgo M, Heeschen C.

PLoS One. 2013 Jun 18;8(6):e66371. doi: 10.1371/journal.pone.0066371. Print 2013.

38.

Soluble GARP has potent antiinflammatory and immunomodulatory impact on human CD4⁺ T cells.

Hahn SA, Stahl HF, Becker C, Correll A, Schneider FJ, Tuettenberg A, Jonuleit H.

Blood. 2013 Aug 15;122(7):1182-91. doi: 10.1182/blood-2012-12-474478. Epub 2013 Jul 1.

PMID:
23818544
39.

Small molecule inhibition of the KRAS-PDEδ interaction impairs oncogenic KRAS signalling.

Zimmermann G, Papke B, Ismail S, Vartak N, Chandra A, Hoffmann M, Hahn SA, Triola G, Wittinghofer A, Bastiaens PI, Waldmann H.

Nature. 2013 May 30;497(7451):638-42. doi: 10.1038/nature12205. Epub 2013 May 22.

PMID:
23698361
40.

Norepinephrine inhibits the migratory activity of pancreatic cancer cells.

Stock AM, Powe DG, Hahn SA, Troost G, Niggemann B, Zänker KS, Entschladen F.

Exp Cell Res. 2013 Jul 15;319(12):1744-58. doi: 10.1016/j.yexcr.2013.04.015. Epub 2013 Apr 29.

PMID:
23639786
41.

Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi.

Sand M, Skrygan M, Sand D, Georgas D, Gambichler T, Hahn SA, Altmeyer P, Bechara FG.

Cell Tissue Res. 2013 Jan;351(1):85-98. doi: 10.1007/s00441-012-1514-5. Epub 2012 Oct 31.

PMID:
23111773
42.

Microarray analysis of microRNA expression in cutaneous squamous cell carcinoma.

Sand M, Skrygan M, Georgas D, Sand D, Hahn SA, Gambichler T, Altmeyer P, Bechara FG.

J Dermatol Sci. 2012 Dec;68(3):119-26. doi: 10.1016/j.jdermsci.2012.09.004. Epub 2012 Sep 13.

PMID:
23026055
43.

Clinical policy: Critical issues in the initial evaluation and management of patients presenting to the emergency department in early pregnancy.

Hahn SA, Lavonas EJ, Mace SE, Napoli AM, Fesmire FM; American College of Emergency Physicians Clinical Policies Subcommittee on Early Pregnancy.

Ann Emerg Med. 2012 Sep;60(3):381-90.e28. doi: 10.1016/j.annemergmed.2012.04.021.

PMID:
22921048
44.

Circulating U2 small nuclear RNA fragments as a novel diagnostic biomarker for pancreatic and colorectal adenocarcinoma.

Baraniskin A, Nöpel-Dünnebacke S, Ahrens M, Jensen SG, Zöllner H, Maghnouj A, Wos A, Mayerle J, Munding J, Kost D, Reinacher-Schick A, Liffers S, Schroers R, Chromik AM, Meyer HE, Uhl W, Klein-Scory S, Weiss FU, Stephan C, Schwarte-Waldhoff I, Lerch MM, Tannapfel A, Schmiegel W, Andersen CL, Hahn SA.

Int J Cancer. 2013 Jan 15;132(2):E48-57. doi: 10.1002/ijc.27791. Epub 2012 Sep 14.

45.

Claudin-4-targeted optical imaging detects pancreatic cancer and its precursor lesions.

Neesse A, Hahnenkamp A, Griesmann H, Buchholz M, Hahn SA, Maghnouj A, Fendrich V, Ring J, Sipos B, Tuveson DA, Bremer C, Gress TM, Michl P.

Gut. 2013 Jul;62(7):1034-43. doi: 10.1136/gutjnl-2012-302577. Epub 2012 Jun 7.

PMID:
22677720
46.

Expression of microRNAs in basal cell carcinoma.

Sand M, Skrygan M, Sand D, Georgas D, Hahn SA, Gambichler T, Altmeyer P, Bechara FG.

Br J Dermatol. 2012 Oct;167(4):847-55. doi: 10.1111/j.1365-2133.2012.11022.x. Epub 2012 Aug 20.

PMID:
22540308
47.

MiR-30a-5p suppresses tumor growth in colon carcinoma by targeting DTL.

Baraniskin A, Birkenkamp-Demtroder K, Maghnouj A, Zöllner H, Munding J, Klein-Scory S, Reinacher-Schick A, Schwarte-Waldhoff I, Schmiegel W, Hahn SA.

Carcinogenesis. 2012 Apr;33(4):732-9. doi: 10.1093/carcin/bgs020. Epub 2012 Jan 27.

PMID:
22287560
48.

Lack of CCR7 expression is rate limiting for lymphatic spread of pancreatic ductal adenocarcinoma.

Sperveslage J, Frank S, Heneweer C, Egberts J, Schniewind B, Buchholz M, Bergmann F, Giese N, Munding J, Hahn SA, Kalthoff H, Klöppel G, Sipos B.

Int J Cancer. 2012 Aug 15;131(4):E371-81. doi: 10.1002/ijc.26502. Epub 2012 Jan 11.

49.

Global microRNA expression profiling of microdissected tissues identifies miR-135b as a novel biomarker for pancreatic ductal adenocarcinoma.

Munding JB, Adai AT, Maghnouj A, Urbanik A, Zöllner H, Liffers ST, Chromik AM, Uhl W, Szafranska-Schwarzbach AE, Tannapfel A, Hahn SA.

Int J Cancer. 2012 Jul 15;131(2):E86-95. doi: 10.1002/ijc.26466. Epub 2011 Nov 19.

50.

MicroRNA-148a is down-regulated in human pancreatic ductal adenocarcinomas and regulates cell survival by targeting CDC25B.

Liffers ST, Munding JB, Vogt M, Kuhlmann JD, Verdoodt B, Nambiar S, Maghnouj A, Mirmohammadsadegh A, Hahn SA, Tannapfel A.

Lab Invest. 2011 Oct;91(10):1472-9. doi: 10.1038/labinvest.2011.99. Epub 2011 Jun 27.

Supplemental Content

Support Center